Results 11 to 20 of about 163,003 (272)

Pleural mesothelioma and lung cancer risks in relation to occupational history and asbestos lung burden. [PDF]

open access: yes, 2015
BACKGROUND: We have conducted a population-based study of pleural mesothelioma patients with occupational histories and measured asbestos lung burdens in occupationally exposed workers and in the general population.
Burdett, G   +9 more
core   +2 more sources

A link between the fibroblast growth factor axis and the miR‐16 family reveals potential new treatment combinations in mesothelioma

open access: yesMolecular Oncology, 2018
Malignant pleural mesothelioma (MPM) is an aggressive malignancy with very limited therapeutic options. Fibroblast growth factor (FGF) signals play important roles in mesothelioma cell growth.
Karin Schelch   +6 more
doaj   +1 more source

A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice

open access: yesBMC Cancer, 2017
Background Cytotoxic chemotherapeutics form the cornerstone of systemic treatment of many cancers. Patients are dosed at maximum tolerated dose (MTD), which is carefully determined in phase I studies.
Wayne J. Aston   +5 more
doaj   +1 more source

Surface reactivity of amphibole asbestos. A comparison between crocidolite and tremolite [PDF]

open access: yes, 2017
Among asbestos minerals, fibrous riebeckite (crocidolite) and tremolite share the amphibole structure but largely differ in terms of their iron content and oxidation state. In asbestos toxicology, iron-generated free radicals are largely held as one of
Andreozzi, Giovanni B.   +4 more
core   +3 more sources

Hemolysis and its impact on cell-free microRNA biomarkers

open access: yesFrontiers in Genetics, 2013
Cell-free microRNAs in plasma and serum have become a promising source of biomarkers for various diseases. Despite rapid progress in this field, there remains a lack of consensus regarding optimal quantification methods, reference genes and quality ...
Michaela B Kirschner   +7 more
doaj   +1 more source

A postmortem case control study of asbestos burden in lungs of malignant mesothelioma cases

open access: yesJournal of Translational Medicine, 2023
Background Asbestos lung content is regarded as the most reliable tool for causal attribution of malignant mesothelioma (MM) to previous asbestos exposures. However, there is a lack of studies on asbestos burden in lungs of MM patients in comparison with
S. D. Visonà   +8 more
doaj   +1 more source

The Use of Geopolymers for the Disposal of Asbestos-containing Materials [PDF]

open access: yesMATEC Web of Conferences, 2020
Asbestos is widely known as a hazardous material and can contribute to many diseases. Its removal and neutralization are complicated, it requires proper preparation and the use of appropriate technology.
Łach Michał   +4 more
doaj   +1 more source

Ongoing downplaying of the carcinogenicity of chrysotile asbestos by vested interests

open access: yesJournal of Occupational Medicine and Toxicology, 2021
Industries that mine, manufacture and sell asbestos or asbestos-containing products have a long tradition of promoting the use of asbestos, while placing the burden of economic and health costs on workers and society.
Xaver Baur, Arthur L. Frank
doaj   +1 more source

Diagnostic limitations of lung fiber counts in asbestos-related diseases

open access: yesThe Journal of Scientific Practice and Integrity, 2023
# Background Lung dust fibre analyses have been used by some pathologists to estimate past asbestos exposure in the workplace and its related health risks.
Joachim Schneider   +3 more
doaj   +1 more source

Tumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptors

open access: yesBMC Research Notes, 2018
Objective Pleural effusion (PE) is a common feature of malignant pleural mesothelioma. These effusions typically contain lymphocytes and malignant cells. We postulated that the PE would be a source of lymphocytes for analysis of tumor immune milieu.
Jonathan Chee   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy